US FDA approves expanded indication for Novartis Leqvio®...
EAST HANOVER, N.J.,July 10, 2023/PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran) to enable earlier use in pat...